Literature DB >> 7870674

Transepithelial transport and metabolism of thyrotropin-releasing hormone (TRH) in monolayers of a human intestinal cell line (Caco-2): evidence for an active transport component?

E Walter1, T Kissel.   

Abstract

Cell culture models for gastrointestinal transport and metabolism are important mechanistic tools. Our studies of Caco-2 monolayers demonstrate heterogeneity in transport characteristics depending on passage number and origin of the cells. In accordance with data obtained in animals and humans, TRH shows a carrier-mediated, saturable transport component, which operates parallel to a passive pathway in Caco-2 cells at passage number 89-99. At low TRH concentrations (< 3 mM) active transport becomes prominent, as demonstrated by the temperature dependence of TRH transport and inhibition experiments. The Michaelis-Menten parameters of the active, saturable transport component are: Km = 1.59 mM and Vmax = 1.84 microM/min. The pH optimum was determined to be at pH 6.0. On the other hand an exclusively paracellular passive route was found with Caco-2 cells at passage number 30-34. These results are also in agreement with observations made by others in cell culture experiments. The aspect of rigorously characterizing the specific Caco-2 clone under investigation is emphasized, especially when active transport mechanisms are suspected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870674     DOI: 10.1023/a:1018953603301

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa.

Authors:  A R Hilgers; R A Conradi; P S Burton
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

2.  Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.

Authors:  J Møss; H Bundgaard
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

3.  Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.

Authors:  A H Dantzig; L Bergin
Journal:  Biochim Biophys Acta       Date:  1990-09-07

4.  Mechanism of L-alpha-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2).

Authors:  M Hu; R T Borchardt
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

5.  Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes.

Authors:  K Inui; M Yamamoto; H Saito
Journal:  J Pharmacol Exp Ther       Date:  1992-04       Impact factor: 4.030

6.  Intestinal absorption mechanisms of thyrotropin-releasing hormone.

Authors:  S Yokohama; T Yoshioka; K Yamashita; N Kitamori
Journal:  J Pharmacobiodyn       Date:  1984-07

7.  Studies on a wide-spectrum intestinal dipeptide uptake system in the monkey and in the human.

Authors:  M Das; A N Radhakrishnan
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

8.  [Pharmacokinetics and pharmacodynamics of protirelin (TRH) in man].

Authors:  L Duntas; F S Keck; U Loos; E F Pfeiffer
Journal:  Dtsch Med Wochenschr       Date:  1988-09-02       Impact factor: 0.628

Review 9.  Prolyl endopeptidase.

Authors:  S Wilk
Journal:  Life Sci       Date:  1983-11-28       Impact factor: 5.037

10.  Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colon.

Authors:  A Blais; P Bissonnette; A Berteloot
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

View more
  5 in total

Review 1.  Intestinal peptide transport systems and oral drug availability.

Authors:  C Y Yang; A H Dantzig; C Pidgeon
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages.

Authors:  H Yu; T J Cook; P J Sinko
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

3.  Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria.

Authors:  Joe Bentz; Michael P O'Connor; Dallas Bednarczyk; Joann Coleman; Caroline Lee; Johan Palm; Y Anne Pak; Elke S Perloff; Eric Reyner; Praveen Balimane; Marie Brännström; Xiaoyan Chu; Christoph Funk; Ailan Guo; Imad Hanna; Krisztina Herédi-Szabó; Kate Hillgren; Libin Li; Evelyn Hollnack-Pusch; Masoud Jamei; Xuena Lin; Andrew K Mason; Sibylle Neuhoff; Aarti Patel; Lalitha Podila; Emile Plise; Ganesh Rajaraman; Laurent Salphati; Eric Sands; Mitchell E Taub; Jan-Shiang Taur; Dietmar Weitz; Heleen M Wortelboer; Cindy Q Xia; Guangqing Xiao; Jocelyn Yabut; Tetsuo Yamagata; Lei Zhang; Harma Ellens
Journal:  Drug Metab Dispos       Date:  2013-04-25       Impact factor: 3.922

4.  Transepithelial transport properties of peptidomimetic thrombin inhibitors in monolayers of a human intestinal cell line (Caco-2) and their correlation to in vivo data.

Authors:  E Walter; T Kissel; M Reers; G Dickneite; D Hoffmann; W Stüber
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

5.  Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers.

Authors:  Dallin Hubbard; Hamidreza Ghandehari; David J Brayden
Journal:  Biomacromolecules       Date:  2014-07-03       Impact factor: 6.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.